Mineralys Therapeutics Statistics

Total Valuation

MLYS has a market cap or net worth of $894.86 million. The enterprise value is $551.83 million.

Market Cap	894.86M
Enterprise Value	551.83M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

MLYS has 65.18 million shares outstanding. The number of shares has increased by 22.76% in one year.

Current Share Class	65.18M
Shares Outstanding	65.18M
Shares Change (YoY)	+22.76%
Shares Change (QoQ)	+6.42%
Owned by Insiders (%)	1.87%
Owned by Institutions (%)	69.85%
Float	43.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.61
P/TBV Ratio	2.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 26.48

Current Ratio	26.48
Quick Ratio	25.63
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -56.31% and return on invested capital (ROIC) is -37.61%.

Return on Equity (ROE)	-56.31%
Return on Assets (ROA)	-35.87%
Return on Invested Capital (ROIC)	-37.61%
Return on Capital Employed (ROCE)	-58.99%
Revenue Per Employee	n/a
Profits Per Employee	-$3.70M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.58% in the last 52 weeks. The beta is -0.18, so MLYS's price volatility has been lower than the market average.

Beta (5Y)	-0.18
52-Week Price Change	+12.58%
50-Day Moving Average	14.72
200-Day Moving Average	12.88
Relative Strength Index (RSI)	37.09
Average Volume (20 Days)	674,328

Short Selling Information

The latest short interest is 6.16 million, so 9.46% of the outstanding shares have been sold short.

Short Interest	6.16M
Short Previous Month	7.21M
Short % of Shares Out	9.46%
Short % of Float	14.17%
Short Ratio (days to cover)	6.98

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-201.49M
Pretax Income	-90.80M
Net Income	-188.51M
EBITDA	-201.44M
EBIT	-201.49M
Earnings Per Share (EPS)	-$3.73

Full Income Statement

Balance Sheet

The company has $343.03 million in cash and n/a in debt, giving a net cash position of $343.03 million or $5.26 per share.

Cash & Cash Equivalents	343.03M
Total Debt	n/a
Net Cash	343.03M
Net Cash Per Share	$5.26
Equity (Book Value)	341.56M
Book Value Per Share	5.26
Working Capital	341.12M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$192.66 million and capital expenditures -$37,000, giving a free cash flow of -$192.70 million.

Operating Cash Flow	-192.66M
Capital Expenditures	-37,000
Free Cash Flow	-192.70M
FCF Per Share	-$2.96

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MLYS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.76%
Shareholder Yield	-22.76%
Earnings Yield	-21.07%
FCF Yield	-21.53%

Analyst Forecast

The average price target for MLYS is $27.00, which is 96.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$27.00
Price Target Difference	96.58%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1